Haukeland University Hospital

Bergen 9 trials 6 recruiting

9 Registered trials

6 Currently recruiting

Organisation

Haukeland University Hospital

Location

Bergen, Norway

Identifier

ORL-000003466

Address

Haukelandsveien 22, 5009, Norway

Departments

Cardiology and intensive care
Department of Gastrointestinal Surgery
Department of Neurology
Department of Pediatrics
Emergency Care Clinic
Klinisk Forskningspost for Barn og unge
Neck and Back Clinic

Clinical trials at this site (9)

Search interface

ZAMBA: Zoledronic Acid for Modic Back Pain. Pending

2024-517345-14-00 Low Back Pain 5
Open-Label followed by a Double-Blind, Placebo-Controlled Study to Investigate the Efficacy and Safety of Infigratinib in Children with Hypo… Recruiting

2024-516822-67-00 Hypochondroplasia 10 2025-08-14
Thrombolysis in Factor Xa-inhibitors Trial (SIFT) Recruiting

2023-509907-34-01 acute ischemic stroke 5 2025-03-10
HR-NBL2: High-risk neuroblastoma study 2.0 of SIOP-Europe- Neuroblastoma/SIOPEN: Randomised, international and multicentric phase 3 study t… Recruiting

2024-514917-36-00 Patients with High Risk Neuroblastoma 5 2024-11-21
Antibiotic THErapy iN vIral Airway iNfections (ATHENIAN): An open labelled randomized controlled pragmatic trial to evaluate the efficacy an… Recruiting

2023-509286-20-00 Viral respiratory tract infection 6 2024-05-15
Clinical Outcome and Cost-effectiveness of Reduced Noradrenaline by Using a Lower Blood Pressure Target in Patients with Cardiogenic Shock f… Recruiting

2024-510892-40-00 Acute myocardial infarction complicated by cardiogenic 6 2024-02-29
Nordic Pancreatic Cancer Trial (NORPACT) – 1 Recruiting

2024-517719-65-00 Resectable pancreatic head cancer 4 2017-02-01
Ocrelizumab VErsus Rituximab off-Label at the Onset of Relapsing MS Disease (OVERLORD-MS) Ended

2024-510716-71-00 Multiple Sclerosis 5 2020-10-21
A Double-Blind, Placebo-Controlled Study to Investigate the Efficacy and Safety of Infigratinib in Children with Achondroplasia Ended

2023-506130-67-00 Achondroplasia 5 2024-08-20